In his latest effort to lower drug costs, President Donald Trump unveiled Friday “Most Favored Nation” pricing deals with nine more pharmaceutical companies. The Blue Cross Blue Shield Association said it is “eager” to work with Trump and Congress on ways to bring down health care costs. The “Most Favored Nation” program calls for drugmakers to price medications sold in the US at the lowest cost available in peer countries. Multipart dealsUnder the deals, drugmakers have agreed to sell medicines to Medicaid at “Most Favored Nation” prices and to launch new medications in the US at that price point. Trump has touted the deals as major victories in driving down drug prices and alleviating a key cost-of-living concern.

Source: CNN December 19, 2025 21:02 UTC